Business: ProQR Therapeutics B.V. is an innovative biopharmaceutical company engaged in the discovery and development of RNA-based therapeutics for the treatment of severe genetic disorders, with an initial focus on Cystic Fibrosis. Utilizing its unique, proprietary RNA repair technologies, the company believes it will be able to treat genetic disorders in which a single protein is defective due to certain types of genetic mutation. ProQR believes that this is a unique approach that offers advantages compared with small molecule, gene therapy and other therapeutic strategies.